Exploring Future Direction For Polycythemia Vera
Exploring Future Direction For Polycythemia Vera reveals several interesting facts.
- Ruben Mesa, MD, Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, discusses the ...
- My name is Heinz Gisslinger from the Medical University of Vienna, and I am presenting at the SOHO 2016 meeting about ...
- Ruben Mesa, MD; Srdan Verstovsek, MD, PhD; and Jamile M. Shammo, MD, describe unmet needs in treating patients with ...
- Um so yes I'll be talking about polythemia
- Expert panelists Harry P. Erba, MD, PhD; Srdan Verstovsek, MD, PhD; Ruben A. Mesa, MD, FACP; Rami Komrokji, MD; and ...
In-Depth Information on Future Direction For Polycythemia Vera
Ruben Mesa, MD, discusses the unmet needs in the management of For more resources and information regarding anticancer targeted therapies: Aligning Real World Practices With Current Best Practices In this CME activity, Ruben A. Mesa, MD, provides practical insights into ... In this episode of our podcast, we dive deep into the management of
The CYTO-PV Study used a hematocrit target of less than 45% in Ruben A. Mesa, MD, FACP, remarks on real-world experience treating patients with
Stay tuned for more updates related to Future Direction For Polycythemia Vera.
